[1] Poisson J, Lemoinne S, Boulanger C, et al. Liver sinusoidal endothelial cells: Physiology and role in liver diseases. J Hepatol,2017,66:212-227.
[2] Marrone G, Shah VH, Gracia-Sancho J. Sinusoidal communication in liver fibrosis and regeneration. J Hepatol,2016,65:608-617.
[3] Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol,2021,18:151-166.
[4] Lafoz E, Ruart M, Anton A, Oncins A, Hernández-Gea V. The Endothelium as a Driver of Liver Fibrosis and Regeneration. Cells,2020,9(4):929.
[5] Matsuda M, Seki E. Hepatic Stellate Cell-Macrophage Crosstalk in Liver Fibrosis and Carcinogenesis. Semin Liver Dis,2020,40(3):307-320.
[6] Sato K, Kennedy L, Liangpunsakul S, et al. Intercellular Communication between Hepatic Cells in Liver Diseases. Int J Mol Sci,2019,20(9):2180.
[7] Nowatari T, Murata S, Nakayama K, et al. Sphingosine 1-phosphate has anti-apoptotic effect on liver sinusoidal endothelial cells and proliferative effect on hepatocytes in a paracrine manner in human. Hepatol Res,2015,45(11):1136-1145.
[8] Chen T, Shi Z, Zhao Y, et al. LncRNA Airn maintains LSEC differentiation to alleviate liver fibrosis via the KLF2-eNOS-sGC pathway. BMC Med,2022,20(1):335.
[9] Winkler M, Staniczek T, Kürschner SW, et al. Endothelial GATA4 controls liver fibrosis and regeneration by preventing a pathogenic switch in angiocrine signaling. J Hepatol,2021,74(2):380-393.
[10] Chen HJ, Liang TM, Lee IJ, et al. Scutellariae radix suppresses LPS-induced liver endothelial cell activation and inhibits hepatic stellate cell migration. J Ethnopharmacol. 2013;150(3):835-842.
[11] Lao Y, Li Y, Zhang P, et al. Targeting Endothelial Erk1/2-Akt Axis as a Regeneration Strategy to Bypass Fibrosis during Chronic Liver Injury in Mice. Mol Ther,2018,26(12):2779-2797.
[12] Fang ZQ, Ruan B, Liu JJ, et al. Notch-triggered maladaptation of liver sinusoidal endothelium aggravates nonalcoholic steatohepatitis through endothelial nitric oxide synthase. Hepatology,2022,76(3):742-758.
[13] Wu X, Shu L, Zhang Z, et al. Adipocyte Fatty Acid Binding Protein Promotes the Onset and Progression of Liver Fibrosis via Mediating the Crosstalk between Liver Sinusoidal Endothelial Cells and Hepatic Stellate Cells. Adv Sci (Weinh), 2021,8(11):e2003721.
[14] Ye Q, Zhou Y, Zhao C,et al. Salidroside Inhibits CCl4-Induced Liver Fibrosis in Mice by Reducing Activation and Migration of HSC Induced by Liver Sinusoidal Endothelial Cell-Derived Exosomal SphK1. Front Pharmacol,2021,12:677810.
[15] Dixon LJ, Barnes M, Tang H, et al. Kupffer cells in the liver. Compr Physiol. 2013;3(2):785-797.
[16] Gao J, Wei B, Liu M, et al. Endothelial p300 Promotes Portal Hypertension and Hepatic Fibrosis Through C-C Motif Chemokine Ligand 2-Mediated Angiocrine Signaling. Hepatology,2021,73(6):2468-2483.
[17] Brozat JF, Brandt EF, Stark M, et al. JAM-A is a multifaceted regulator in hepatic fibrogenesis, supporting LSEC integrity and stellate cell quiescence. Liver Int, 2022,42(5):1185-1203.
[18] Hammoutene A, Biquard L, Lasselin J, et al. A defect in endothelial autophagy occurs in patients with non-alcoholic steatohepatitis and promotes inflammation and fibrosis. J Hepatol,2020,72(3):528-538.
[19] Bravo M, Raurell I, Barberá A, et al. Synergic effect of atorvastatin and ambrisentan on sinusoidal and hemodynamic alterations in a rat model of NASH. Dis Model Mech,2021,14(5):dmm048884.
[20] Tripathi DM, Hassan M, Siddiqui H, et al. Cirrhotic Endothelial Progenitor Cells Enhance Liver Angiogenesis and Fibrosis and Aggravate Portal Hypertension in Bile Duct-Ligated Cirrhotic Rats. Front Physiol,2020,11:617. |
